Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia
Open accessThe DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Abstract
In subjects with schizophrenia, impairments in working memory are associated with dysfunction of the dorsolateral prefrontal cortex (DLPFC). This dysfunction appears to be due, at least in part, to abnormalities in gamma-aminobutyric acid (GABA)-mediated inhibitory circuitry. To test the hypothesis that altered GABA-mediated circuitry in the DLPFC of subjects with schizophrenia reflects expression changes of genes that encode selective presynaptic and postsynaptic components of GABA neurotransmission, we conducted a systematic expression analysis of GABA-related transcripts in the DLPFC of 14 pairs of schizophrenia and age-, sex- and post-mortem interval-matched control subjects using a customized DNA microarray with enhanced sensitivity and specificity. Subjects with schizophrenia exhibited expression deficits in GABA-related transcripts encoding (1) presynaptic regulators of GABA neurotransmission (67 kDa isoform of glutamic acid decarboxylase (GAD(67)) and GABA transporter 1), (2) neuropeptides (somatostatin (SST), neuropeptide Y (NPY) and cholecystokinin (CCK)) and (3) GABA(A) receptor subunits (alpha1, alpha4, beta3, gamma2 and delta). Real-time qPCR and/or in situ hybridization confirmed the deficits for six representative transcripts tested in the same pairs and in an extended cohort, respectively. In contrast, GAD(67), SST and alpha1 subunit mRNA levels, as assessed by in situ hybridization, were not altered in the DLPFC of monkeys chronically exposed to antipsychotic medications. These findings suggest that schizophrenia is associated with alterations in inhibitory inputs from SST/NPY-containing and CCK-containing subpopulations of GABA neurons and in the signaling via certain GABA(A) receptors that mediate synaptic (phasic) or extrasynaptic (tonic) inhibition. In concert with previous findings, these data suggest that working memory dysfunction in schizophrenia is mediated by altered GABA neurotransmission in certain DLPFC microcircuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an expression analysis of DLPFC from SZ patients indicated the reduced expression of several GABA-related genes, including neuropeptides and both presynaptic and postsynaptic markers 183.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [183]
In the citing paper
“Despite variable results, consistent findings across studies can be identified, including dysregulation of GABAergic signalling102; downregulation of oligodendrocyte- and myelination-related genes103, mitochondrial function or energy metabolism104, and synaptic genes105; and upregulation of immune and inflammatory genes106.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [102]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Conflict monitoring and cognitive control
Botvinick, M. M., Braver, T. S., Barch, D. M., Carter, C. S., & Cohen, J. D. (2001) · Psychological Review · doi:10.1037/0033-295x.108.3.624 · Cited by 7,351
Applied Linear Statistical Models
(1997) · Technometrics · doi:10.1080/00401706.1997.10485141 · Cited by 7,185
Neurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Research works printed but not linked: 2
- Melchitzky DS, Lewis DA . Synaptic targets of somatostatin-labeled axon terminals in monkey prefrontal cortex. Soc Neurosci Abstr 2005; 675: 6.
- Kim AM, Matzilevich DA, Walsh JP, Benes FM, Woo TW . Parvalbumin-containing neurons and disturbances of prefrontal cortical circuitry in schizophrenia. Soc Neurosci Abstr 2005; 912: 1.
Cited by
Items 301–400 of 503
An integrative functional genomics approach for discovering biomarkers in schizophrenia
Vawter, M. P., Mamdani, F., & Macciardi, F. M. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr036 · Cited by 25
Georgiev, D. D., Yoshihara, T., Kawabata, R., Matsubara, T., Tsubomoto, M., Minabe, Y., Lewis, D. A., & Hashimoto, T. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw022 · Cited by 24
Self-citationReciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia
Kimoto, S., Glausier, J. R., Fish, K. N., Volk, D. W., Bazmi, H. H., Arion, D., Datta, D., & Lewis, D. A. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv139 · Cited by 23
Self-citationReduced in vivo visual cortex GABA in schizophrenia, a replication in a recent onset sample
Yoon, J. H., Maddock, R. J., Cui, E., Minzenberg, M., Niendam, T. A., Lesh, T. A., Solomon, M., Ragland, J. D., & Carter, C. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.025 · Cited by 22
Schizophrenia and the Epigenetic Hypothesis
Grayson, D. R. (2010) · Epigenomics · doi:10.2217/epi.10.22 · Cited by 24
Zachlod, D., Bludau, S., Cichon, S., Palomero‐Gallagher, N., & Amunts, K. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119286 · Cited by 26
Agetsuma, M., Sato, I., Tanaka, Y. R., Carrillo‐Reid, L., Kasai, A., Noritake, A., Arai, Y., Yoshitomo, M., Inagaki, T., Yukawa, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41547-5 · Cited by 25
Mazhari, S., Badcock, J. C., Waters, F., Dragović, M., Badcock, D. R., & Jablensky, A. V. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.09.002 · Cited by 23
Eggan, S. M., Lazarus, M. S., Stoyak, S. R., Volk, D. W., Glausier, J. R., Huang, Z. J., & Lewis, D. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.014 · Cited by 22
Self-citationProtein Interaction Networks Link Schizophrenia Risk Loci to Synaptic Function
Schwarz, E., Izmailov, R., Lió, P., & Meyer‐Lindenberg, A. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw035 · Cited by 21
Larimore, J. L., Zlatic, S. A., Arnold, M., Singleton, K. S., Cross, R., Rudolph, H., Bruegge, M. V., Sweetman, A., Garza, C., Whisnant, E., et al. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00028 · Cited by 23
Quantitative assessment of fibroblast growth factor receptor 1 expression in neurons and glia
Choubey, L., Collette, J. C., & Smith, K. M. (2017) · PeerJ · doi:10.7717/peerj.3173 · Cited by 22
Polyadenylation of mRNA as a novel regulatory mechanism of gene expression in temporal lobe epilepsy
Parras, A., de Diego-García, L., Alves, M., Beamer, E. H., Conte, G., Jimenez-Mateos, E. M., Morgan, J., Ollà, I., Hernandez-Santana, Y., Delanty, N., et al. (2020) · Brain · doi:10.1093/brain/awaa168 · Cited by 23
Pan, Y., Hsieh, M. H., & Liu, S.-K. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00931.x · Cited by 22
Malt, E. A., Juhasz, K., Malt, U. F., & Naumann, T. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00059 · Cited by 25
Wearne, T. A., Parker, L. M., Franklin, J. L., Goodchild, A. K., & Cornish, J. L. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.038 · Cited by 21
Verdurand, M., Fillman, S. G., Weickert, C. S., & Zavitsanou, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052724 · Cited by 24
Umeda, K., Iritani, S., Fujishiro, H., Sekiguchi, H., Torii, Y., Habuchi, C., Kuroda, K., Kaibuchi, K., & Ozaki, N. (2016) · Synapse · doi:10.1002/syn.21924 · Cited by 22
Frajman, A., Maggio, N., Muler, I., Haroutunian, V. H., Katsel, P., Yitzhaky, A., Weiser, M., & Hertzberg, L. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.027 · Cited by 21
Beyond the γ-aminobutyric acid hypothesis of schizophrenia
Fujihara, K. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1161608 · Cited by 24
Hughes, H., Brady, L. J., & Schoonover, K. E. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1440834 · Cited by 22
ErbB4 in Laminated Brain Structures: A Neurodevelopmental Approach to Schizophrenia
Pérez‐García, C. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00472 · Cited by 21
A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
Kim, Y., Choi, J., & Park, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040734 · Cited by 21
Wang, Y., Fasching, L., Wu, F., Šuvakov, M., Huttner, A. J., Berretta, S., Roberts, R. C., Leckman, J. F., Fernandez, T. V., Abyzov, A. S., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.12.022 · Cited by 22
Cell-based therapies for the treatment of schizophrenia
Donegan, J. J., & Lodge, D. J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.010 · Cited by 25
Corder, K. M., Cortes, M. A., Bartley, A. F., Lear, S. A., Lubin, F. D., & Dobrunz, L. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200809 · Cited by 19
Southey, B. R., Zhang, P., Keever-Keigher, M. R., Rymut, H. E., Johnson, R. W., Sweedler, J. V., & Rodriguez‐Zas, S. L. (2021) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2021.01.332 · Cited by 20
Preterm Birth Alters the Maturation of the GABAergic System in the Human Prefrontal Cortex
Lacaille, H., Vacher, C., & Penn, A. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.827370 · Cited by 21
Contributions of Glutamate and GABA Systems to the Neurobiology and Treatment of Schizophrenia
Krystal, J. H., & Moghaddam, B. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch21 · Cited by 20
Hervig, M. E.-S., Thomsen, M. S., Kalló, I., & Mikkelsen, J. D. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.028 · Cited by 18
Peselmann, N., Schmitt, A., Gebicke‐Haerter, P. J., & Zink, M. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0367-y · Cited by 19
Modeling Interneuron Dysfunction in Schizophrenia
Schmidt, M. J., & Mirnics, K. (2012) · Developmental Neuroscience · doi:10.1159/000336731 · Cited by 16
Self-citationChromosomal Conformations and Epigenomic Regulation in Schizophrenia
Rajarajan, P., Jiang, Y., Kassim, B. S., & Akbarian, S. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.022 · Cited by 16
Abd-Eldaim, F., Farroh, K. Y., Safina, F. S., Fouad, M. R., Darwish, O. S., Emam, S., & Abdel-Halim, K. Y. (2023) · Archives of Phytopathology and Plant Protection · doi:10.1080/03235408.2023.2289218 · Cited by 16
Purves-Tyson, T. D., Allen, K. M., Fung, S. J., Rothmond, D. A., Noble, P. L., Handelsman, D. J., & Weickert, C. S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.05.040 · Cited by 17
Rahman, T., Weickert, C. S., Harms, L. R., Meehan, C. L., Schall, U., Todd, J., Hodgson, D. M., Michie, P. T., & Purves-Tyson, T. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-58449-x · Cited by 16
The effect of alterations of schizophrenia-associated genes on gamma band oscillations
Metzner, C., Mäki‐Marttunen, T., Karni, G., McMahon-Cole, H., & Steuber, V. (2022) · Schizophrenia · doi:10.1038/s41537-022-00255-7 · Cited by 16
Berretta, S., Heckers, S., & Benes, F. M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.019 · Cited by 16
Gene expression profiling of the brain: Pondering facts and fiction
Mitchell, A., & Mirnics, K. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.06.001 · Cited by 18
Self-citationAlterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia
Lewis, D. A., & Glausier, J. R. (2016) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-30596-7_3 · Cited by 15
Self-citationGomes, F. V., Edelson, J. R., Volk, D. W., & Grace, A. A. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.04.030 · Cited by 15
Self-citationWearne, T. A., Parker, L. M., Franklin, J. L., Goodchild, A. K., & Cornish, J. L. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.018 · Cited by 15
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting
Sandoval, K. E., & WITT, K. A. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001117 · Cited by 19
Prefrontal cortical circuits in social behaviors: an overview
Cao, W., Li, H., & Luo, J. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300743 · Cited by 18
Mascio, G., Bucci, D., Notartomaso, S., Liberatore, F., Antenucci, N., Scarselli, P., Imbriglio, T., Caruso, S., Gradini, R., Cannella, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01210-3 · Cited by 15
Mayeli, A., Sonnenschein, S. F., Yushmanov, V. E., Wilson, J. D., Blazer, A., Foran, W., Perica, M. I., Calabro, F. J., Luna, B., Hetherington, H. P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415846 · Cited by 15
Adraoui, F. W., Douw, L., Martens, G. J. M., & Maas, D. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097680 · Cited by 31
Mahadevan, A. S., Cornblath, E. J., Lydon‐Staley, D. M., Zhou, D., Parkes, L., Larsen, B., Adebimpe, A., Kahn, A. E., Gur, R. C., Gur, R. E., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02121-z · Cited by 15
Coevolution in the timing of GABAergic and pyramidal neuron maturation in primates
Charvet, C. J., Šimić, G., Kostović, I., Knezović, V., Vukšić, M., Leko, M. B., Takahashi, E., Sherwood, C. C., Wolfe, M. D., & Finlay, B. L. (2017) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2017.1169 · Cited by 17
Liu, D., Zinski, A. L., Mishra, A., Noh, H., Park, G.-H., Qin, Y., Olorife, O., Park, J. M., Abani, C. P., Park, J. S., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01654-z · Cited by 15
Neural noise and cortical inhibition in schizophrenia
Carment, L., Dupin, L., Guedj, L., Térémetz, M., Cuenca, M., Krebs, M., Amado, I., Maier, M. A., & Lindberg, P. G. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.06.015 · Cited by 15
Pathway Analysis of the Human Brain Transcriptome in Disease
Kavanagh, T., Mills, J. D., Kim, W. S., Halliday, G. M., & Janitz, M. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9940-0 · Cited by 17
Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T. (2008) · Neurotoxicity Research · doi:10.1007/bf03033811 · Cited by 14
Kirenskaya, A. V., Storozheva, Z. I., Алексеевна, Г. М., & Sewell, R. D. E. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0881-7 · Cited by 13
Shang, Y., Chen, R., Li, F., Zhang, H., Wang, H., & Zhang, T. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113184 · Cited by 13
Aksić, M., Poleksić, J., Aleksić, D., Petronijević, N., Radonjić, N. V., Jakovcevski, M., Kapor, S., Divac, N., Filipović, B., & Jakovčevski, I. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.670766 · Cited by 14
The beta component of gamma-band auditory steady-state responses in patients with schizophrenia
Metzner, C., & Steuber, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-99793-w · Cited by 14
Schoonover, K. E., Dienel, S. J., Bazmi, H. H., Enwright, J. F., & Lewis, D. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01854-x · Cited by 14
Self-citationInflammation in Schizophrenia: The Role of Disordered Oscillatory Mechanisms
Speers, L. J., & Bilkey, D. K. (2025) · Cells · doi:10.3390/cells14090650 · Cited by 14
Cortical interneurons in schizophrenia – cause or effect?
Prkačin, M. V., Banovac, I., Petanjek, Z., & Hladnik, A. (2023) · Croatian Medical Journal · doi:10.3325/cmj.2023.64.110 · Cited by 12
Reduced cortical somatostatin gene expression in a rat model of maternal immune activation
Duchatel, R. J., Harms, L. R., Meehan, C. L., Michie, P. T., Bigland, M. J., Smith, D. W., Jobling, P., Hodgson, D. M., & Tooney, P. A. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112621 · Cited by 13
Abi‐Dargham, A., & Grace, A. A. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch20 · Cited by 17
Danovich, L., Weinreb, O., Youdim, M. B. H., & Silver, H. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000106 · Cited by 11
Balan, S., Yamada, K., Iwayama, Y., Hashimoto, T., Toyota, T., Shimamoto, C., Maekawa, M., Takagai, S., Wakuda, T., Kameno, Y., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.003 · Cited by 13
Self-citationDowling, K. F., Dienel, S. J., Barile, Z. J., Bazmi, H. H., & Lewis, D. A. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.04.003 · Cited by 12
Self-citationSustained versus transient brain responses in schizophrenia: the role of intrinsic neural activity
Ethridge, L. E., Moratti, S., Gao, Y., Keil, A., & Clementz, B. A. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.016 · Cited by 11
Volk, D. W., & Lewis, D. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00105-4 · Cited by 11
Self-citationRaymann, S., Schalbetter, S. M., Schaer, R., Bernhardt, A. C., Mueller, F. S., Meyer, U., & Weber‐Stadlbauer, U. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac207 · Cited by 10
The role of cell adhesion molecule IgSF9b at the inhibitory synapse and psychiatric disease
Clarin, J. D., Reddy, N., Alexandropoulos, C., & Gao, W. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105476 · Cited by 10
Loss of dysbindin-1 affects GABAergic transmission in the PFC
Trantham‐Davidson, H., & Lavín, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05285-1 · Cited by 13
Analysis of global gene expression at seven brain regions of patients with schizophrenia
Karpiński, P., Samochowiec, J., Sasiadek, M. M., Łaczmański, Ł., & Misiak, B. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.032 · Cited by 10
Granados-Rojas, L., Jerónimo-Cruz, K., Juárez-Zepeda, T. E., Rodríguez, M. T., Tovar, A. R., Rodríguez‐Jurado, R., Carmona‐Aparicio, L., Cárdenas‐Rodríguez, N., Coballase-Urrutía, E., Ruíz-Garcìa, M., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00673 · Cited by 10
In silico hippocampal modeling for multi-target pharmacotherapy in schizophrenia
Sherif, M. A., Neymotin, S. A., & Lytton, W. W. (2020) · Schizophrenia · doi:10.1038/s41537-020-00109-0 · Cited by 11
Cortical control of chandelier cells in neural codes
Jung, K., Choi, Y., & Kwon, H. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.992409 · Cited by 12
Usui, K., Kirihara, K., Araki, T., Tada, M., Koshiyama, D., Fujioka, M., Nishimura, R., Ando, S., Koike, S., Sugiyama, H., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad346 · Cited by 11
Morosawa, S., Iritani, S., Fujishiro, H., Sekiguchi, H., Torii, Y., Habuchi, C., Kuroda, K., Kaibuchi, K., & Ozaki, N. (2017) · Neuropeptides · doi:10.1016/j.npep.2016.12.010 · Cited by 12
Pedrosa, E., Kaushik, S., & Lachman, H. M. (2009) · Journal of Neurogenetics · doi:10.3109/01677060903305658 · Cited by 10
Dienel, S. J., Wade, K., Fish, K. N., & Lewis, D. A. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.01.010 · Cited by 10
Self-citationCale, J. A., Chauhan, E. J., Cleaver, J. J., Fusciardi, A. R., McCann, S., Waters, H. C., Žavbi, J., & King, M. V. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03987-y · Cited by 11
Kim, D.-H., Choi, B., Jeon, W. K., & Han, J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.09.007 · Cited by 9
Förster, A., Model, V., Gos, T., Frodl, T., Schiltz, K., Dobrowolny, H., Meyer-Lotz, G., Guest, P. C., Mawrin, C., Bernstein, H., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.028 · Cited by 9
The GABRB3 Polymorphism and its Association with Schizophrenia
Liu, Y., Sun, X.-F., Ding, M., Liu, Y., Zhang, X., Pang, H., Xing, J., Xuan, J., Xia, X., Wang, B., et al. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-1003-0 · Cited by 9
Tang, X., Lyu, G., Chen, M., Huang, W., & Lin, Y. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00677 · Cited by 10
Migratory cortical interneuron-specific transcriptome abnormalities in schizophrenia
Park, J. M., Liu, D., Park, G.-H., Noh, H., Ni, P., Yin, C., Huang, W., & Chung, S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.054 · Cited by 9
Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors
Luoni, A., Gass, P., Brambilla, P., Ruggeri, M., Riva, M. A., & Inta, D. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0728-z · Cited by 9
Cheng, B.-F., Liang, Y., & Wu, Q. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i11.107604 · Cited by 8
Cardarelli, R. A., Martin, R. F., Jaaro-Peled, H., Sawa, A., Powell, E. M., & O’Donnell, P. (2018) · Complex Psychiatry · doi:10.1159/000488030 · Cited by 8
Adolescent Maturation of Cortical Dopamine
O’Donnell, P. (2010) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_11 · Cited by 8
Negrón-Oyarzo, I., Dib, T., Chacana-Véliz, L., Quilodrán, N. L., & Urrutia-Piñones, J. (2024) · Frontiers in Neural Circuits · doi:10.3389/fncir.2024.1286111 · Cited by 8
He, H., Long, J., Song, X., Li, Q., Niu, L., Peng, L., Wei, X., & Zhang, R. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.031 · Cited by 9
Imbriglio, T., Verhaeghe, R., Martinello, K., Pascarelli, M. T., Chece, G., Bucci, D., Notartomaso, S., Quattromani, M. J., Mascio, G., Scalabrì, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901093rrr · Cited by 7
García‐López, R., Pombero, A., Estirado, A., Geijo‐Barrientos, E., & Martínez, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.693919 · Cited by 7
da Rocha, R. H., Fernandes, C. A., Bignotto, T. S., Margarido, V. P., Tencatt, L. F. C., da Graça., W. J., & Gubiani, É. A. (2021) · Organisms Diversity & Evolution · doi:10.1007/s13127-021-00534-8 · Cited by 7
Fish, K. N., Rocco, B. R., Wilson, J. D., & Lewis, D. A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.12.004 · Cited by 6
Self-citationGene expression profiling as functional readout of rodent models for psychiatric disorders
Molteni, R., Macchi, F., & Riva, M. A. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1648-0 · Cited by 6
Effects of Medicinal Plants and Phytochemicals on Schizophrenia
Raju, N. R., Rashmitha, S., -, S. P., Torres, E. A., Kishor, M. R., & Achar, R. R. (2023) · Wiley eBooks · doi:10.1002/9781119794127.ch4 · Cited by 9
Bosker, F. J., Gladkevich, A. V., Pietersen, C. Y., Kooi, K. A., Bakker, P. L., Gerbens, F., den Boer, J. A., Korf, J., & Meerman, G. T. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.03.003 · Cited by 6
Psychiatric disorders and epigenetics.
Koçak, E. E., & Ertuğrul, A. (2012) · PubMed · Cited by 8
Cameron, D., Vinh, N., Prapaiwongs, P., Perry, E. A., Walters, J., Li, M., O’Donovan, M. C., & Bray, N. J. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae083 · Cited by 7
Okuda, T., Kimoto, S., Kawabata, R., Bian, Y., Tsubomoto, M., Okamura, K., Enwright, J. F., Kikuchi, M., Lewis, D. A., & Hashimoto, T. (2024) · Psychological Medicine · doi:10.1017/s0033291724002344 · Cited by 6
Self-citation
Metadata
- Authors
- Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Lewis, D A
- Venue
- Molecular Psychiatry
- Published
- 2007-05-01
- Volume
- 13
- Issue
- 2
- Pages
- 147-161
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2882638
- OpenAlex
- W2126843605
- Cited by
- 490
- References
- 262
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 17 · 2023: 17 · 2022: 15 · 2021: 24 · 2020: 29 · 2019: 22 · 2018: 26 · 2017: 25 · 2016: 33 · 2015: 42 · 2014: 25 · 2013: 29 · 2012: 27
- FWCI
- 20.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Eli Lilly and Company
- National Institutes of Health
- Medical Center, University of Pittsburgh
- National Institute of Mental Health (R01MH043784, MH43784, MH 45156, MH-067234, MH070786, K02MH070786, R01MH067234, P50MH045156, R37MH043784)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD015052)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, dorsolateral prefrontal cortex, GABAergic neurotransmission, gene expression, working memory, GAD67, GABA transporter 1, somatostatin, neuropeptide Y, cholecystokinin, GABAA receptor subunits, presynaptic inhibition, tonic inhibition, antipsychotic exposure, inhibitory interneurons
- MeSH terms
- Olanzapine, Adult, Aged, Animals, Benzodiazepines, Chloroquinolinols, Female, Gene Expression Regulation, Glutamate Decarboxylase, Humans, Macaca fascicularis, Male, Middle Aged, Neuropeptides, Receptors, GABA-A, Schizophrenia, Antipsychotic Agents, Case-Control Studies, Prefrontal Cortex, Oligonucleotide Array Sequence Analysis, Protein Subunits, GABA Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.